Westside Investment Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
Westside Investment Management's NVAX Position: Q1 2023 in Review
Westside Investment Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 51 shares.
Westside Investment Management first reported a position in NVAX in Q3 2020 and held it in 6 quarters. The position peaked at $2.79K in Q4 2020. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.
- Westside Investment Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
- Westside Investment Management sold 51 Novavax shares in Q1 2023.
- Westside Investment Management first reported a position in Novavax in Q3 2020 and held it in 6 quarters.
- Westside Investment Management's Novavax position peaked at $2.79K in Q4 2020.
- 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.
Based on Westside Investment Management's 13F filing for Q1 2023, filed 17 May 2023.